Immune Checkpoint Inhibitor M7824 and the Immunocytokine M9241 in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Advanced Pancreas Cancer

Clinical trial NCT04327986 · TERMINATED

Trial details

NCT number: NCT04327986
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Histologically or Cytologically Confirmed Pancreatic Cancer Unresectable or Borderline Resectable Pancreatic Cancer Pancreatic Neoplasms Pancreatic Cancer Metastatic Pancreatic Cancer

Start date: 2021-06-15
Primary completion: 2022-01-18
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.